In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for Does BPC 157 Cause Erectile Dysfunction? Evidence and Safe Treatments Bolt Pharmacy The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype BPC 157: The peptide with big claims and scant evidence STAT